IV Mirus and Dr
When you are well enough, you can reach out to our Miami GLP-1 lawsuit attorneys for a free case review
**BPC-157, a synthetic gastric pentadecapeptide studied primarily in animal models for tissue repair, gut healing, and anti-inflammatory effects, remains unapproved by the FDA as a finished drug with only limited small-scale human data available.** It was placed in Category 2 in 2023 due to concerns over immunogenicity, peptide impurities, and insufficient safety information for compounding under Section 503A
Side effects to discuss early Common GLP-1 side effects are usually gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, burping, reflux, decreased appetite, and sometimes fatigue or headache
The answer lies in the diversity of mechanisms I have just described